Cargando…
Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies
BACKGROUND: The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066968/ https://www.ncbi.nlm.nih.gov/pubmed/27749933 http://dx.doi.org/10.1371/journal.pone.0164617 |
_version_ | 1782460572214755328 |
---|---|
author | Brandt, Alexander U. Meinert-Bohn, Elena Rinnenthal, Jan Leo Zimmermann, Hanna Mikolajczak, Janine Oberwahrenbrock, Timm Papazoglou, Sebastian Pfüller, Caspar F. Schinzel, Johann Tackenberg, Björn Paul, Friedemann Hahn, Katrin Bellmann-Strobl, Judith |
author_facet | Brandt, Alexander U. Meinert-Bohn, Elena Rinnenthal, Jan Leo Zimmermann, Hanna Mikolajczak, Janine Oberwahrenbrock, Timm Papazoglou, Sebastian Pfüller, Caspar F. Schinzel, Johann Tackenberg, Björn Paul, Friedemann Hahn, Katrin Bellmann-Strobl, Judith |
author_sort | Brandt, Alexander U. |
collection | PubMed |
description | BACKGROUND: The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this study was to identify potential structural and functional alterations in the afferent visual system in HNPP patients. METHODS: Twenty HNPP patients and 18 matched healthy controls (HC) were recruited in a cross-sectional study. Participants underwent neurological examination including visual acuity, visual evoked potential (VEP) examination, optical coherence tomography (OCT), and magnetic resonance imaging with calculation of brain atrophy, regarding grey and white matter, and voxel based morphometry (VBM), in addition answered the National Eye Institute’s 39-item Visual Functioning Questionnaire (NEI-VFQ). Thirteen patients and 6 HC were additionally examined with magnetic resonance spectroscopy (MRS). RESULTS: All patients had normal visual acuity, but reported reduced peripheral vision in comparison to HC in the NEI-VFQ (p = 0.036). VEP latency was prolonged in patients (P(100) = 103.7±5.7 ms) in comparison to healthy subjects (P(100) = 99.7±4.2 ms, p = 0.007). In OCT, peripapillary retinal nerve fiber layer thickness RNFL was decreased in the nasal sector (90.0±15.5 vs. 101.8±16.5, p = 0.013), and lower nasal sector RNFL correlated with prolonged VEP latency (Rho = -0.405, p = 0.012). MRS revealed reduced tNAA (731.4±45.4 vs. 814.9±62.1, p = 0.017) and tCr (373.8±22.2 vs. 418.7±31.1, p = 0.002) in the visual cortex in patients vs. HC. Whole brain volume, grey and white matter volume, VBM and metabolites in a MRS sensory cortex control voxel did not differ significantly between patients and HC. CONCLUSION: PMP22 deletion leads to functional, metabolic and macro-structural alterations in the afferent visual system of HNPP patients. Our data suggest a functional relevance of these changes for peripheral vision, which warrants further investigation and confirmation. |
format | Online Article Text |
id | pubmed-5066968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-50669682016-10-27 Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies Brandt, Alexander U. Meinert-Bohn, Elena Rinnenthal, Jan Leo Zimmermann, Hanna Mikolajczak, Janine Oberwahrenbrock, Timm Papazoglou, Sebastian Pfüller, Caspar F. Schinzel, Johann Tackenberg, Björn Paul, Friedemann Hahn, Katrin Bellmann-Strobl, Judith PLoS One Research Article BACKGROUND: The PMP22 gene encodes a protein integral to peripheral myelin. Its deletion leads to hereditary neuropathy with liability to pressure palsies (HNPP). PMP22 is not expressed in the adult central nervous system, but previous studies suggest a role in CNS myelin development. The objective of this study was to identify potential structural and functional alterations in the afferent visual system in HNPP patients. METHODS: Twenty HNPP patients and 18 matched healthy controls (HC) were recruited in a cross-sectional study. Participants underwent neurological examination including visual acuity, visual evoked potential (VEP) examination, optical coherence tomography (OCT), and magnetic resonance imaging with calculation of brain atrophy, regarding grey and white matter, and voxel based morphometry (VBM), in addition answered the National Eye Institute’s 39-item Visual Functioning Questionnaire (NEI-VFQ). Thirteen patients and 6 HC were additionally examined with magnetic resonance spectroscopy (MRS). RESULTS: All patients had normal visual acuity, but reported reduced peripheral vision in comparison to HC in the NEI-VFQ (p = 0.036). VEP latency was prolonged in patients (P(100) = 103.7±5.7 ms) in comparison to healthy subjects (P(100) = 99.7±4.2 ms, p = 0.007). In OCT, peripapillary retinal nerve fiber layer thickness RNFL was decreased in the nasal sector (90.0±15.5 vs. 101.8±16.5, p = 0.013), and lower nasal sector RNFL correlated with prolonged VEP latency (Rho = -0.405, p = 0.012). MRS revealed reduced tNAA (731.4±45.4 vs. 814.9±62.1, p = 0.017) and tCr (373.8±22.2 vs. 418.7±31.1, p = 0.002) in the visual cortex in patients vs. HC. Whole brain volume, grey and white matter volume, VBM and metabolites in a MRS sensory cortex control voxel did not differ significantly between patients and HC. CONCLUSION: PMP22 deletion leads to functional, metabolic and macro-structural alterations in the afferent visual system of HNPP patients. Our data suggest a functional relevance of these changes for peripheral vision, which warrants further investigation and confirmation. Public Library of Science 2016-10-17 /pmc/articles/PMC5066968/ /pubmed/27749933 http://dx.doi.org/10.1371/journal.pone.0164617 Text en © 2016 Brandt et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Brandt, Alexander U. Meinert-Bohn, Elena Rinnenthal, Jan Leo Zimmermann, Hanna Mikolajczak, Janine Oberwahrenbrock, Timm Papazoglou, Sebastian Pfüller, Caspar F. Schinzel, Johann Tackenberg, Björn Paul, Friedemann Hahn, Katrin Bellmann-Strobl, Judith Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title | Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title_full | Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title_fullStr | Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title_full_unstemmed | Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title_short | Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies |
title_sort | afferent visual pathway affection in patients with pmp22 deletion-related hereditary neuropathy with liability to pressure palsies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066968/ https://www.ncbi.nlm.nih.gov/pubmed/27749933 http://dx.doi.org/10.1371/journal.pone.0164617 |
work_keys_str_mv | AT brandtalexanderu afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT meinertbohnelena afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT rinnenthaljanleo afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT zimmermannhanna afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT mikolajczakjanine afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT oberwahrenbrocktimm afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT papazoglousebastian afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT pfullercasparf afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT schinzeljohann afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT tackenbergbjorn afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT paulfriedemann afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT hahnkatrin afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies AT bellmannstrobljudith afferentvisualpathwayaffectioninpatientswithpmp22deletionrelatedhereditaryneuropathywithliabilitytopressurepalsies |